Propanc Biopharma, Inc. — Director's Dealing 2016

Sep 27, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Propanc Health Group Corp (PPCH)
CIK: 0001517681
Period of Report: 2015-02-04

Reporting Person: Nathanielsz James Andrew (Director, CEO, CFO, Secretary, Treasurer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-02-04	Common Stock, par value $0.001	J	33259350	—	Acquired	42711111	Indirect

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-04-14	Stock Option (Right to Buy)	$.03	A	71500000	Acquired	2021-04-14	Common Stock, par value $0.001 (71500000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Series A Preferred Stock, par value $0.01	500000	Direct
Series B Preferred Stock, par value $0.01	1	Direct

Footnotes

F1: These shares were issued to Mr. Nathanielsz pursuant to a Debt Settlement Agreement with the Issuer dated 2/4/15 in satisfaction of approximately $33,259 due to him in connection with certain non-interest bearing loans.

F2: This option vests as follows: 23,833,333 shares on 4/14/16, 23,833,333 shares on 4/14/17 and 23,833,334 shares on 4/14/18.